AKOYA BIOSCIENCES INC (AKYA)

US00974H1041 - Common Stock

4.69  -0.04 (-0.85%)

After market: 4.69 0 (0%)

News Image
24 days ago - InvestorPlace

AKYA Stock Earnings: Akoya Biosciences Beats EPS, Beats Revenue for Q4 2023

AKYA stock results show that Akoya Biosciences beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023.

News Image
24 days ago - BusinessInsider

AKYA Stock Earnings: Akoya Biosciences Beats EPS, Beats Revenue for Q4 2023

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Akoya Biosciences (NASDAQ:AKYA) just reported results for the fourth quarter of...

News Image
24 days ago - Akoya Biosciences, Inc.

Akoya Reports Record Revenue in the Fourth Quarter of 2023 and Provides Full Year 2024 Financial Outlook

Q4 2023 revenue $26.5 million and FY 2023 revenue $96.6 millionGuiding FY 2024 revenue range $114.0-118.0 million and operating cash flow breakeven by YE...

News Image
2 months ago - Akoya Biosciences, Inc.

Akoya to Report Fourth Quarter and Full Year 2023 Financial Results on March 4th, 2024 and Participate at an Upcoming Investor Conference

MARLBOROUGH, Mass., Feb. 08, 2024 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced...

News Image
2 months ago - Akoya Biosciences, Inc.

Akoya Biosciences’ Technology Enables Queensland Spatial Biology Centre to Revolutionize the Diagnosis and Treatment of Cancer and Other Diseases

PhenoCycler®-Fusion system selected as the Centre’s platform technology for advanced spatial biology studies

News Image
2 months ago - Akoya Biosciences, Inc.

Akoya Biosciences’ Technology Enables Queensland Spatial Biology Centre to Revolutionize the Diagnosis and Treatment of Cancer and Other Diseases

PhenoCycler®-Fusion system selected as the Centre’s platform technology for advanced spatial biology studies...

News Image
3 months ago - Akoya Biosciences, Inc.

Akoya Biosciences Announces that Garry Nolan, Ph.D., James Allison, Ph.D., and Padmanee Sharma, M.D., Ph.D., Join Newly Created Scientific Advisory Board

Leading immunotherapy and immunobiology experts will offer strategic direction and expertise in translational, clinical, and diagnostic applications of Akoya’s spatial biology solutions

News Image
3 months ago - Seeking Alpha

It's JPM time! Which medtechs are expected to issue updates this week? (NASDAQ:ILMN)

Several medtech companies are expected to release financial updates this coming week when the huge annual JP Morgan Healthcare Conference convenes in SF. Read more here here.

News Image
3 months ago - Akoya Biosciences, Inc.

Akoya Biosciences and Thermo Fisher Scientific Announce a License and Distribution Agreement to Deliver Spatial Multiomics Workflow

The Thermo Fisher Scientific ViewRNA technology combined with Akoya’s market leading spatial biology solutions will enable rapid, whole-slide imaging of RNA and protein biomarkers

News Image
3 months ago - Akoya Biosciences, Inc.

Akoya Biosciences Deploys the MaxFuse Algorithm Co-Developed by Dr. Garry Nolan and His Laboratory at Stanford University for Multiomic Integration of Spatial and Single-cell Data on the Enable Medicine Platform

MaxFuse enables matching and integration of datasets from spatial proteomics, spatial transcriptomics, single-cell sequencing, or other modalities ...

News Image
3 months ago - Akoya Biosciences, Inc.

Akoya Biosciences Announces Preliminary Financial Results for the Fourth Quarter and Full Year 2023 and Provides 2024 Outlook

MARLBOROUGH, Mass., Jan. 07, 2024 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced...

News Image
3 months ago - Akoya Biosciences, Inc.

Akoya Biosciences and Thermo Fisher Scientific Announce a License and Distribution Agreement to Deliver Spatial Multiomics Workflow

The Thermo Fisher Scientific ViewRNA technology combined with Akoya’s market leading spatial biology solutions will enable rapid, whole-slide imaging of...

News Image
3 months ago - Akoya Biosciences, Inc.

Akoya to Participate at 42nd Annual J.P. Morgan Healthcare Conference

MARLBOROUGH, Mass., Dec. 20, 2023 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced...

News Image
5 months ago - Akoya Biosciences, Inc.

Akoya Reports Record Revenue in the Third Quarter of 2023 and Reiterates Full Year 2023 Revenue Guidance

Q3 2023 revenue $25.2 million, 34% y/y growth Reiterating FY 2023 revenue guidance range of $95-98 million MARLBOROUGH, Mass., Nov. 08, 2023 (GLOBE...

News Image
5 months ago - Akoya Biosciences, Inc.

Akoya Biosciences to Showcase New Spatial Biology 2.0 Solutions and Spatial Phenotyping Data at SITC 2023

Spatial Biology 2.0 solutions enable discovery and translational workflows at an unprecedented speed and scale Global network of CROs providing Akoya’s...

News Image
5 months ago - Akoya Biosciences, Inc.

Akoya Biosciences Announces Peer-Reviewed Publication Using Ultrahigh-Plex Spatial Phenotyping of Head and Neck Cancer to Identify Distinct Immune and Metabolic Signatures

MARLBOROUGH, Mass., Oct. 17, 2023 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced...

News Image
6 months ago - Akoya Biosciences, Inc.

Akoya to Report Third Quarter 2023 Financial Results on November 8th, 2023

MARLBOROUGH, Mass., Oct. 11, 2023 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced...

News Image
6 months ago - Akoya Biosciences, Inc.

Akoya Biosciences Sets a New Standard for Scaling Spatial Biology with the Launch of 2.0 Platforms

PhenoCycler-Fusion 2.0 enhancements enable the highest throughput workflow for spatial discovery studies.PhenoImager HT 2.0 delivers a 5x greater speed...

News Image
8 months ago - Market News Video

Akoya Biosciences is Now Oversold (AKYA)